Noxopharm Annual Report 2022

Noxopharm Limited 40 Weighted average interest rate 1 year or less Between 1 and 2 years Between 2 and 5 years Over 5 years Remaining contractual maturities Consolidated - 2022 % $ $ $ $ $ Non-derivatives Non-interest bearing Trade payables - 810,470 - - - 810,470 Other payables - 985,251 - - - 985,251 Lease liability - 160,624 - - - 160,624 Total non-derivatives 1,956,345 - - - 1,956,345 Weighted average interest rate 1 year or less Between 1 and 2 years Between 2 and 5 years Over 5 years Remaining contractual maturities Consolidated - 2021 % $ $ $ $ $ Non-derivatives Non-interest bearing Trade payables - 959,493 - - - 959,493 Other payables - 5,170,677 - - - 5,170,677 Lease liability - 231,166 117,642 - - 348,808 Total non-derivatives 6,361,336 117,642 - - 6,478,978 The cash flows in the maturity analysis above are not expected to occur significantly earlier than contractually disclosed above. Fair value of financial instruments The fair values of cash and cash equivalents, trade and other receivables and trade and other payables approximate to their carrying amounts largely due to being liquid assets or liabilities that will be settled within 12 months.

RkJQdWJsaXNoZXIy MjE2NDg3